doi:10.1016/S1470-2045(04)01382-8
NSABP PROTOCOL C-10: RESULTS A Phase II Trial of 5-Fluorouracil, Leucovorin and Oxaliplatin (mFOLFOX6) Plus Bevacizumab for Patients with Unresectable.
Issues of Mitosis “The Life and Times of the Cell”
Identifying Tumors Expressing Predictive Markers: Lessons Learned From HER2
ANTI-TUBERCULOSIS DRUGS Tuberculosis (TB) is a disease that has affected mankind for centuries and dates as far back as ancient Egyptian times. is caused.
ANTI-TUBERCULOSIS DRUGS
BCIRG006 - Randomized Phase III Trial Comparing AC-T vs AC-TH vs TCH in HER2 Positive Node Positive or High Risk Node Negative Breast Cancer Initial efficacy.
